Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Insulin Resistance Intervention After Stroke (IRIS) Trial

NCT00091949 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT00091949
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00091949 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Insulin Resistance Intervention After Stroke (IRIS) Trial
Lead sponsor
Yale University
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2005
Completion date
November 30, 2015
Enrollment
3,876 (actual)
Sites
183

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, myocardial infarction, stroke